Surgery Partners Stock Probability Of Bankruptcy

SGRY Stock

USD 22.89 0.52 2.22%

Surgery Partners' odds of distress is below 50% at this time. It has small probability of experiencing financial hardship in the next few years. Probability of bankruptcy shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Surgery balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Surgery Partners Piotroski F Score and Surgery Partners Altman Z Score analysis.

For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Market Cap is likely to rise to about 3.7 B in 2024, whereas Enterprise Value is likely to drop slightly above 1.9 B in 2024.

Surgery Partners Company probability of bankruptcy Analysis

Surgery Partners' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Surgery Partners Probability Of Bankruptcy

Less than 42%

Most of Surgery Partners' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgery Partners is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Surgery Partners probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Surgery Partners odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Surgery Partners financial health.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgery Partners. If investors know Surgery will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgery Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.47)

Revenue Per Share

23.69

Quarterly Revenue Growth

0.143

Return On Assets

0.039

Return On Equity

0.0308

The market value of Surgery Partners is measured differently than its book value, which is the value of Surgery that is recorded on the company's balance sheet. Investors also form their own opinion of Surgery Partners' value that differs from its market value or its book value, called intrinsic value, which is Surgery Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgery Partners' market value can be influenced by many factors that don't directly affect Surgery Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Surgery Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgery Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgery Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Surgery Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Surgery Partners is extremely important. It helps to project a fair market value of Surgery Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Surgery Partners' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Surgery Partners' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Surgery Partners' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment	Net Tangible Assets	Current Deferred Revenue	Long Term Investments	Short Long Term Debt	Common Stock	Short Term Investments	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.77	0.97	-0.71	0.97	0.98	0.99	1.0	0.93	0.98	0.97	0.63	0.89	-0.02	-0.1	0.87	0.97	0.68	0.81	0.96	0.72	0.35	0.45	-0.62
Total Stockholder Equity	0.77		0.66	-0.75	0.84	0.66	0.78	0.74	0.64	0.77	0.72	0.38	0.9	0.13	0.21	0.87	0.76	0.86	0.64	0.73	0.98	0.52	0.72	-0.91
Net Debt	0.97	0.66		-0.71	0.92	1.0	0.97	0.98	0.94	0.95	0.97	0.68	0.87	-0.06	-0.15	0.77	0.94	0.55	0.84	0.95	0.62	0.26	0.3	-0.5
Retained Earnings	-0.71	-0.75	-0.71		-0.78	-0.69	-0.77	-0.66	-0.6	-0.77	-0.74	-0.37	-0.86	-0.33	-0.38	-0.73	-0.61	-0.76	-0.73	-0.66	-0.8	-0.4	-0.62	0.78
Accounts Payable	0.97	0.84	0.92	-0.78		0.91	0.98	0.96	0.85	0.96	0.95	0.56	0.92	0.05	0.02	0.94	0.94	0.83	0.78	0.92	0.81	0.46	0.56	-0.72
Long Term Debt	0.98	0.66	1.0	-0.69	0.91		0.97	0.98	0.95	0.96	0.96	0.7	0.85	-0.04	-0.15	0.75	0.94	0.54	0.81	0.95	0.62	0.23	0.32	-0.5
Net Receivables	0.99	0.78	0.97	-0.77	0.98	0.97		0.98	0.91	0.99	0.96	0.64	0.9	0.04	-0.06	0.87	0.95	0.72	0.79	0.94	0.74	0.36	0.49	-0.64
Good Will	1.0	0.74	0.98	-0.66	0.96	0.98	0.98		0.94	0.97	0.96	0.67	0.87	-0.07	-0.17	0.84	0.97	0.63	0.8	0.96	0.69	0.32	0.39	-0.57
Total Liab	0.93	0.64	0.94	-0.6	0.85	0.95	0.91	0.94		0.92	0.9	0.57	0.79	-0.02	-0.24	0.72	0.89	0.47	0.76	0.9	0.56	0.16	0.35	-0.48
Total Current Assets	0.98	0.77	0.95	-0.77	0.96	0.96	0.99	0.97	0.92		0.96	0.59	0.88	0.13	0.02	0.84	0.94	0.7	0.78	0.94	0.72	0.28	0.56	-0.66
Short Term Debt	0.97	0.72	0.97	-0.74	0.95	0.96	0.96	0.96	0.9	0.96		0.52	0.91	0.01	0.0	0.85	0.96	0.66	0.85	0.97	0.69	0.35	0.38	-0.57
Intangible Assets	0.63	0.38	0.68	-0.37	0.56	0.7	0.64	0.67	0.57	0.59	0.52		0.49	-0.26	-0.36	0.37	0.57	0.21	0.36	0.51	0.34	0.18	0.05	-0.2
Property Plant Equipment	0.89	0.9	0.87	-0.86	0.92	0.85	0.9	0.87	0.79	0.88	0.91	0.49		0.05	0.19	0.87	0.88	0.75	0.85	0.89	0.91	0.47	0.52	-0.78
Net Tangible Assets	-0.02	0.13	-0.06	-0.33	0.05	-0.04	0.04	-0.07	-0.02	0.13	0.01	-0.26	0.05		0.5	-0.05	-0.13	0.28	-0.12	-0.03	0.17	-0.48	0.66	-0.49
Current Deferred Revenue	-0.1	0.21	-0.15	-0.38	0.02	-0.15	-0.06	-0.17	-0.24	0.02	0.0	-0.36	0.19	0.5		0.1	-0.07	0.33	0.06	-0.01	0.34	0.13	0.51	-0.4
Long Term Investments	0.87	0.87	0.77	-0.73	0.94	0.75	0.87	0.84	0.72	0.84	0.85	0.37	0.87	-0.05	0.1		0.85	0.9	0.72	0.81	0.85	0.68	0.59	-0.73
Short Long Term Debt	0.97	0.76	0.94	-0.61	0.94	0.94	0.95	0.97	0.89	0.94	0.96	0.57	0.88	-0.13	-0.07	0.85		0.63	0.82	0.98	0.7	0.37	0.37	-0.55
Common Stock	0.68	0.86	0.55	-0.76	0.83	0.54	0.72	0.63	0.47	0.7	0.66	0.21	0.75	0.28	0.33	0.9	0.63		0.51	0.61	0.86	0.58	0.79	-0.87
Short Term Investments	0.81	0.64	0.84	-0.73	0.78	0.81	0.79	0.8	0.76	0.78	0.85	0.36	0.85	-0.12	0.06	0.72	0.82	0.51		0.88	0.65	0.33	0.22	-0.5
Long Term Debt Total	0.96	0.73	0.95	-0.66	0.92	0.95	0.94	0.96	0.9	0.94	0.97	0.51	0.89	-0.03	-0.01	0.81	0.98	0.61	0.88		0.7	0.27	0.37	-0.58
Capital Surpluse	0.72	0.98	0.62	-0.8	0.81	0.62	0.74	0.69	0.56	0.72	0.69	0.34	0.91	0.17	0.34	0.85	0.7	0.86	0.65	0.7		0.53	0.72	-0.93
Net Invested Capital	0.35	0.52	0.26	-0.4	0.46	0.23	0.36	0.32	0.16	0.28	0.35	0.18	0.47	-0.48	0.13	0.68	0.37	0.58	0.33	0.27	0.53		0.18	-0.29
Net Working Capital	0.45	0.72	0.3	-0.62	0.56	0.32	0.49	0.39	0.35	0.56	0.38	0.05	0.52	0.66	0.51	0.59	0.37	0.79	0.22	0.37	0.72	0.18		-0.87
Capital Stock	-0.62	-0.91	-0.5	0.78	-0.72	-0.5	-0.64	-0.57	-0.48	-0.66	-0.57	-0.2	-0.78	-0.49	-0.4	-0.73	-0.55	-0.87	-0.5	-0.58	-0.93	-0.29	-0.87

Click cells to compare fundamentals

The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.

Competition

Predict Surgery Partners

Based on the latest financial disclosure, Surgery Partners has a Probability Of Bankruptcy of 42.0%. This is 2.98% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 5.45% lower than that of the firm.

Surgery Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgery Partners' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Surgery Partners could also be used in its relative valuation, which is a method of valuing Surgery Partners by comparing valuation metrics of similar companies.

Surgery Partners is currently under evaluation in probability of bankruptcy category among its peers.

Surgery Partners Main Bankruptcy Drivers

	2019	2020	2021	2022	2023	2024 (projected)
Return On Assets	0.009184	2.4E-4	0.0116	0.013	(0.00173)	(0.001817)
Asset Turnover	0.29	0.38	0.36	0.34	0.4	0.43
Net Debt	2.8B	2.9B	2.9B	2.6B	2.9B	2.3B
Total Current Liabilities	397.6M	556.8M	536.8M	493.4M	523M	371.2M
Non Current Liabilities Total	2.9B	3.2B	3.3B	2.9B	3.0B	2.6B
Total Assets	5.0B	5.4B	6.1B	6.7B	6.9B	4.6B
Total Current Assets	525.5M	801.5M	946.1M	921M	895M	626.5M
Total Cash From Operating Activities	129.5M	246.9M	87.1M	158.8M	293.8M	308.5M

Surgery Partners ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Surgery Partners' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Surgery Partners' managers, analysts, and investors.

Environmental

Governance

Social

Surgery Fundamentals

	Return On Equity	0.0308
	Return On Asset	0.039
	Profit Margin	(0.02) %
	Operating Margin	0.13 %
	Current Valuation	6.27 B
	Shares Outstanding	127.11 M
	Shares Owned By Insiders	1.12 %
	Shares Owned By Institutions	98.88 %
	Number Of Shares Shorted	10.07 M
	Price To Earning	61.84 X
	Price To Book	1.57 X
	Price To Sales	1.00 X
	Revenue	2.74 B
	Gross Profit	574.9 M
	EBITDA	480.8 M
	Net Income	(11.9 M)
	Cash And Equivalents	227.4 M
	Cash Per Share	2.58 X
	Total Debt	3.06 B
	Debt To Equity	1.44 %
	Current Ratio	1.51 X
	Book Value Per Share	15.00 X
	Cash Flow From Operations	293.8 M
	Short Ratio	10.96 X
	Earnings Per Share	(0.47) X
	Price To Earnings To Growth	1.66 X
	Target Price	36.29
	Number Of Employees	10.5 K
	Beta	2.77
	Market Capitalization	2.98 B
	Total Asset	6.88 B
	Retained Earnings	(569.2 M)
	Working Capital	372 M
	Current Asset	310.96 M
	Current Liabilities	181.29 M
	Net Asset	6.88 B

About Surgery Partners Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Surgery Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgery Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgery Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Surgery Partners Stock Probability Of Bankruptcy

Surgery Partners Company probability of bankruptcy Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current Surgery Partners Probability Of Bankruptcy

Surgery Probability Of Bankruptcy Driver Correlations

Surgery Probability Of Bankruptcy Peer Comparison

Surgery Partners Main Bankruptcy Drivers

Surgery Partners ESG Sustainability

Surgery Fundamentals

About Surgery Partners Fundamental Analysis

Also Currently Popular

Additional Tools for Surgery Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY